Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C

Nobuyoshi Fukushima(Nagasaki Medical Center), Michio Sata(Kurume University), Tatsuya Ide(Kurume University), Akio Takata(Kurume University), Ryoko Kuromatsu(Kurume University), Masahito Nakano(Kurume University), Takumi Kawaguchi(Kurume University), Eiji Ando(Kurume University), Shuji Sumie(Kurume University), Teruko Arinaga‐Hino(Kurume University), Takuji Torimura(Omuta hospital)
Hepatology Research
August 30, 2010
10.1111/j.1872-034x.2010.00699.x
Cited by 19

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504